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SUMMARY
Mitochondrial DNA (mtDNA) segregation associated with donor-recipient mtDNA mismatch in mito-
chondria replacement therapy leads to unknown risks. Here, to explore whether matching mtDNA
haplotypes contributes to ameliorating segregation, we reproduced various degrees of heteroplas-
mic mice with three single nucleotide polymorphisms to monitor segregation severity. ‘‘Segregation’’
presented in tissues of heteroplasmic mice containing low-level donor mtDNA heteroplasmy, and dis-
appeared as donor mtDNA heteroplasmy levels ascended. Meanwhile, we found that distribution of
donor mtDNA among the blastomeres of preimplantation embryos from the heteroplasmic mice
shared the same tendency as that in adult tissues. Statistical analysis showed that no selective
replication of donor mtDNA occurred during lifespan. Tracking donor mtDNA distribution showed
that uneven distribution of donor mtDNA among embryonic blastomeres gradually became even as
donor mtDNA heteroplasmy increased, indicating that the ‘‘segregation’’ in tissues was inherited
from the uneven distribution. Our finding suggested that donor-recipient mtDNA matching could
circumvent segregation in mitochondria replacement therapy.
INTRODUCTION
Mitochondrial replacement has the potential to reduce the transmission of inherited mitochondrial dis-
eases (Wang et al., 2014; Paull et al., 2013; Graven et al., 2010; Tachibana et al., 2009). However, mitochon-
drial replacement will inevitably result in trace levels of heteroplasmy (Paull et al., 2013; Graven et al., 2010;
Tachibana et al., 2009). Although such trace levels of heteroplasmy do not exceed a pathogenic threshold,
if the pathogenic maternal mitochondrial DNA (mtDNA) is given a selective advantage, it is possible that it
achieves dominance and manifests a pathogenic phenotype through the process of segregation, a com-
mon phenomenon in tissues of patients with mitochondrial disease (Frederiksen et al., 2006; Nishizuka
et al., 1998). Recent studies of human mitochondrial replacement show sharp drifts of pathogenic mtDNA
haplotype on a cellular level (Hyslop et al., 2016; Kang et al., 2016; Yamada et al., 2016), indicating that the
nuclear genome preferentially regulates the replication and segregation of the native pathogenic mito-
chondria. Thus the requirement of a functional match between donor and recipient mtDNA, as well as
between the mtDNA and nuclear genome, is of the utmost importance in clinical applications of mitochon-
dria replacement (Latorre-Pellicer et al., 2016; Reinhardt et al., 2013, Sharpley et al., 2012; St John and
Campbell, 2010). Previous study suggested that the segregation of donor mtDNA in mitochondria replace-
ment could be alleviated if the donor mtDNA haplotype matches with the recipient mtDNA haplotype
(Latorre-Pellicer et al., 2016; Røyrvik et al., 2016).
Obviously, the optimal recipient mitochondria would have the same haplotype as the donor. However, it is
impossible to have two identical haplotypes of mtDNA in humans (He et al., 2010). However, the shorter the
genetic distance between haplotypes, the less pronounced is the segregation bias. Therefore, exploring
haplotype matching between donor and recipient mtDNA is particularly important for eliminating segre-
gation of donor mtDNA. As tissue-specific segregation of different mtDNA genotypes is also common in
heteroplasmic mice created from ooplasm or nuclear transfer, various heteroplasmic mice models were
used to elucidate the mechanisms for controlling segregation of different mtDNA genotypes (Jokinen
et al., 2015; Neupane et al., 2015; Sato et al., 2007; Battersby et al., 2005; Takeda et al., 2000; Jenuth
et al., 1997). Among these models, heteroplasmic mice constituted by NZB and C57BL/6N were the domi-
nant heteroplasmic models with 106 single nucleotide polymorphism (SNP) differences. In addition,
Burgstaller et al. found highly significant positive correlation between individual tissue-specific segrega-
tion and mtDNA genetic distance in specific heteroplasmic mice generated using wild mice in Europe
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and C57BL/6N, where the wild mice display a spectrum of genetic distance (18, 86, 107, and 416 SNP
differences at mtDNA) with C57BL/6N (Burgstaller et al., 2014a). Common segregation present in those
heteroplasmic mice indicated that none of the models above underwent haplotype matching, leading
to the absence of related progress in segregation.
Here we therefore intend to shorten the distance between the donor and recipient mtDNA haplotypes
to explore whether matching mtDNA haplotypes between donor and recipient mtDNA can circumvent
the segregation bias toward donor mtDNA in tissues of mitochondria replacement mice (Figures S1A
and S1B). We had established a specific model of heteroplasmic mice from NZW/Lac J and B6D2F1
(C57/BL63DBA) using mitochondria replacement from our past study (Wang et al., 2014). The
mtDNA genotypes of NZW strain differ from those of C57 strain at only three SNPs, making them ideal
models for matching mtDNA haplotypes. To study the effect of matching mtDNA haplotypes on the
tissue segregation, we reared offspring of the heteroplasmic mice to test whether matching mtDNA
haplotypes between ‘‘donor’’ and ‘‘recipient’’ can circumvent the segregation of donor mtDNA
(Figure S1C).
RESULTS
Tissue-Specific ‘‘Segregation’’ Gradually Disappeared with the Increase of Donor mtDNA
Mean Heteroplasmy in Adult Mice
To explore whether matching mtDNA haplotypes can circumvent the segregation bias, we first sought to
test whether the segregation occurred in different tissues from heteroplasmic mice with 3 SNP difference
(Table S1), which was derived as described using mitochondria replacement technique (Wang et al., 2014).
To avoid the potential impact of heteroplasmy level and trauma from mitochondria replacement manipu-
lation on segregation behavior, heteroplasmic mice from the mitochondria replacement founder were
used, which possessed naturally inherited levels of heteroplasmy. Pyrosequencing, which has a 1% detec-
tion threshold, 100% sensitivity, and 100% specificity (Hyslop et al., 2016; Wang et al., 2014; Blakely et al.,
2013; White et al., 2005) (Figure S2), was adopted to measure the level of donor mtDNA heteroplasmy with
primary and second primers (Table S2, also see Transparent Methods). The donor mtDNA heteroplasmy
was measured with pyrosequencing in 16 tissues from 37 heteroplasmic mice that were sacrificed as adults
(6–8 months old) (Figure 1A). The mean heteroplasmy level of each adult displaces the natural range (from
1.86% to 38.13%) (Figure 1B and Table S3). The heteroplasmic value of 16 tissues showed similar regional
distribution (p > 0.05) (Figure 1C), which initially indicated that segregation of donor mtDNA does not
appear in different tissues of the heteroplasmic mice with 3 SNP difference. After incorporation of different
tissues into the corresponding germ layer, it was found that there was no significant difference in donor
mtDNA heteroplasmy between the three germ layers (p > 0.05) (Figure 1D). Then we compared the distri-
bution of donor mtDNA in individual tissues of each adult mouse using normalized variance (V0(h)) calcu-
lation as a way to measure the dispersion of donor mtDNA heteroplasmy. A drastic dispersion of donor
mtDNA presented in individual tissues of adult mice with lesser than 10% donor mtDNA, evidenced by
the greater V0(h) (r = 0.53, p < 0.001) (Figure 1E). However, a much narrower distribution with few devia-
tions appeared in individual tissues of adult mice with 10%–20%, or greater than 20%, donor mtDNA, sup-
ported by the low V0(h) (Figure 1E).
Distribution of Donor mtDNA in the Blastomeres of Preimplantation Embryos Shared the
Same Tendency as that in Adult Tissues
It is known that no net replication of mtDNA takes place before embryo implantation. Therefore each sub-
sequent cell division reduces the amount of mtDNA within the daughter cells by about 50% (Carling et al.,
2011). Next, to explore whether ‘‘segregation’’ actually occurs at lower levels of heteroplasmy in adult tis-
sues, we observed the distribution of the two different mtDNAgenotypes in each blastomere of embryos at
2-cell, 4-cell, and 8-cell stages from the heteroplasmic mice. As the adult tissues of the heteroplasmic mice,
embryos at 2-cell, 4-cell, and 8-cell stages maintained a natural distribution value, ranging from 1.95 to
39.63, 1.81 to 54.24, and 2.57 to 51.91, respectively (Figures 2A–2C, Tables S4–S6). Similar to adult tissues,
we observed that distribution of donor mtDNA heteroplasmy in each blastomere became less diverse as
the mean levels of donor mtDNA heteroplasmy gradually increased in 2-, 4-, and 8-cell embryos, respec-
tively. It was witnessed that V0(h) values present a negative correlation with the mean heteroplasmy of
embryos at 2-, 4-, and 8-cell stages (r =0.45, p < 0.05 for 2-cell stage; r =0.58, p < 0.0001 for 4-cell stage;
r = 0.48, p < 0.005 for 8-cell stage) (Figure 2D).
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No Selective Replication of DonormtDNA Took Place during the Progressive Cleavage across
Developmental Stages
To relate the similar distribution trend of donor mtDNA seen in adult tissues with those in blastomeres of
cleaving embryos, we compared the dispersion of donor mtDNA from 2-cell with that from adult stage us-
ing several statistical comparison methods. We first observed the spread trends from 2-cell to adult stage.
The spread of donor mtDNA heteroplasmy between daughter blastomeres within each embryo, calculated
as the heteroplasmic range and V0(h) values, increased gradually from the 2-cell through the 4-cell to 8-cell
groups (p < 0.05) (Figures 3A–3D). These phenomena are consistent with recent studies’ findings, which
showed increasing cell-to-cell heteroplasmy variability through early embryonic cleavages (Lee et al.,
2012; Johnston et al., 2015; Johnston and Jones, 2015, 2016). However, the spread trend returned to the
original level as that of 2-cell embryos as development progresses to adult stage (Figures 3A–3D). Then
we further found that adult tissues share a similar distribution of heteroplasmy with early embryos at 2-,
4-, and 8-cell stages (p > 0.05), calculated as mean heteroplasmy (Figure 3E), frequency distribution (Fig-
ure 3F), and cumulative probability distribution (Figure 3G). Thus, from the spread trends and the distribu-
tion, it can be deduced that the distribution of donor mtDNA in adult tissues depends on the distribution
present in early embryos, suggesting that no selective replication of donor mtDNA took place during the
progressive cleavage from the 2- to 4- to 8-cell stages extending to adult.
Figure 1. Tissue-Specific Segregation Disappeared with the Increase of Donor mtDNA Mean Heteroplasmy in Adult Mice
(A) Schematic model of heteroplasmic mice and dissected tissues in this study.
(B) Heteroplasmy of donor mtDNA in individual tissues from heteroplasmic mice with different heteroplasmic levels.
(C) Comparison of heteroplasmic distribution in 16 tissues from 37 mice (p > 0.05, Friedman test). Data are represented as scatterplot with mean G SD.
(D) Comparison of mean heteroplasmy levels in the ectoderm, endoderm, and mesoderm (p > 0.05, Mann-Whitney test). Data are represented as
mean G SD.
(E) Negative correlation between heteroplasmic levels (green) and V0(h) (red) in 16 tissues of each mouse (r = 0.53, p < 0.001, Spearman correlation test).
Error bars indicate SD, with the mean value.
See also Table S3.
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Tracking Donor mtDNA Distribution Exhibited that Low Level of Donor mtDNA
Heteroplasmy Resulted in Its Uneven Inheritance during Early Embryonic Cleavage
To explore why donor mtDNA deviation occur in tissues and blastomeres in the <10% group, we gener-
ated heteroplasmic oocytes to observe the distribution of donor mtDNA via spindle-chromosome com-
plex transfer (spindle transfer) (Figure 4A) (Wang et al., 2014). Briefly, the donor mitochondria were
labeled with 250 nM MitoTracker Red. Then spindle transfer was performed between the stained oo-
cytes (donor) and unstained oocytes (recipient) (Figures 4A and 4B and Video S1). Differing amounts
of donor mtDNA were fused into an enucleated recipient oocyte, resulting in varying levels of hetero-
plasmy (<10% and >10%; here we only use >10% as past results showed no significant difference
between the 10% to 20% and the >20% groups). The levels of heteroplasmy were calculated from
the volume ratio (on average 10%:90%) by measuring the diameters of karyoplasts (carrying donor
mtDNA). After the oocytes were fertilized in vitro and development proceeded, red mitochondria
Figure 2. Distribution of Donor mtDNA in the Blastomeres of Pre-implantation Embryos Shared the Same Tendency as that in Adult Tissues
(A) Schematic model of embryos and dissected blastomeres of embryos at 2-cell stage. Heteroplasmy distribution of donor mtDNA in blastomeres of
embryos at 2-cell stage from heteroplasmic mice.
(B) Schematic model of embryos and dissected blastomeres of embryos at 4-cell stage. Heteroplasmy distribution of donor mtDNA in blastomeres of
embryos at 4-cell stage from heteroplasmic mice.
(C) Schematic model of embryos and dissected blastomeres of embryos at 8-cell stage. Heteroplasmy distribution of donor mtDNA in blastomeres of
embryos at 8-cell stage from heteroplasmic mice.
(D) Negative correlation between donor mtDNA heteroplasmy (green) and V0(h) (red) values in blastomeres of embryos at 2, 4, and 8-cell stage (r = 0.45,
p < 0.05 for 2-cell stage; r = 0.58, p < 0.0001 for 4-cell stage; r = 0.48, p < 0.005 for 8-cell stage. Spearman correlation test).
Error bars indicate SD, with the mean value. See also Tables S4–S6.
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distribution was monitored in individual blastomeres of embryos at the 2-, 4-, and 8-cell stages and the
blastocyst. A distinct correlation was observed between the distribution of donor mitochondria and the
level of heteroplasmy. For <10% group, uneven and even configurations of red mitochondria distribu-
tion were found in the preimplantation embryos from 2-cell to blastocyst stage. In the uneven group,
the number of red mitochondria in each blastomere varied significantly under confocal microscope,
with no red mitochondria in several of the blastomeres (Figures 4B and S3–S6). By contrast, almost
equal numbers of red granules were distributed in each blastomere in the even group (Figures 4B
and S3–S6). However, in cells with higher levels of heteroplasmy (>10%), we observed only even distri-
bution of stained mitochondria, with cells portraying close to equal levels of heteroplasmy (Figures 4B
Figure 3. No selective replication of donor mtDNA took place during the progressive cleavage across developmental stages
(A and B) (A) Spread of donor mtDNA heteroplasmy from embryonic blastomere to adult tissue expressed by heteroplasmy range (maximum or minimum
heteroplasmy value minus the mean median of heteroplasmy value). The mean median is defined as half of the sum of maximum and minimum values. Light
bar = maximum  median = maximum  maximum + minimum2 = maximum  minimum2 ; dark bar =
minimummedian=minimum maximum + minimum2 =  maximum  minimum2 (B) V0(h) values of embryonic blastomeres and adult tissue.
(C) Comparison of the spread ranges among embryos at 2-, 4-, and 8-cell stage and adults. Data are represented as mean G SD.
(D) Comparison of V0(h) values among embryos at 2-, 4-, and 8-cell stage and adults. Different letters indicate p values < 0.05 (Mann-Whitney test); error bars
indicate SD. See also Tables S3–S6.
(E) Comparison of mean heteroplasmy values of embryos at 2-, 4-, and 8-cell stage and adult tissues (p > 0.05, Mann-Whitney test). Data are represented as
scatterplot with mean G SD.
(F) Frequency histogram of the donor mtDNA heteroplasmy of embryos at 2-, 4-, and 8-cell stage and adult tissues.
(G) Cumulative probability distribution functions for the heteroplasmy of embryos at 2-, 4-, and 8-cell stage and adult tissues. (p > 0.05, Kolmogorov-Smirnov
test).
See also Tables S3–S6.
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and S3–S6). Furthermore, statistical comparison found that there were significant differences be-
tween <10% uneven and <10% even or >10% groups for donor mtDNA distribution in each blastomere
of embryos at 2-, 4-, and 8-cell stages and blastocysts (Figures 4C and S3–S6 and Tables S7–S10). On
the contrary, there were no obvious differences between <10% even and >10% groups for the distribu-
tion in each blastomere of embryos at 2-, 4-, and 8-cell stages and blastocysts (Figures 4C and S3–S6
and Tables S7–S10). This suggests that disproportionate variance increase can arise from partitioning
noise with low mitochondrial volumes.
DISCUSSION
As we know, segregation of mutant mtDNA is a universal event during individual development (Burgstaller
et al., 2014b). The coexistence of two kinds of mitochondria and its mtDNA may have fatal consequences
for the development of offspring (Schon et al., 2012). Mitochondrial replacement technology will inevitably
lead to the coexistence of two kinds of mitochondria andmtDNA, so the public has been worried about the
potential safety risks since its conception. This study demonstrated that matching the haplotypes of the
donor and recipient mtDNA has the potential to circumvent segregation bias and prevent the occurrence
of mitochondrial diseases.
Figure 4. Tracking Donor mtDNA Distribution in Pre-implantation Embryos Exhibited that Low Level of Heteroplasmy Led to Its Uneven
Inheritance during Cleavage
(A) Schematic model showing how differing amounts of donor mitochondria were transferred into the recipient oocytes, resulting in the formation of
the <10% heteroplasmy group and the >10% heteroplasmy group (here we only use >10% as past results showed no significant difference between the 10%–
20% and >20% group). Depicts the two possible outcomes for each group: even distribution or uneven distribution.
(B) The spindle transfer manipulation that resulted into the two groups of differing heteroplasmy (images were taken with Nikon TE, 2000 microscope, 40X);
the two separate groups of heteroplasmic oocytes with different heteroplasmy of donor mtDNA; the final outcome of the two groups, with the <10% group
displaying both even and uneven distributions of donor mtDNA in pre-implantation development; the >10% group only portraying an even distribution in
pre-implantation development (images were taken with Leica confocal scanningmicroscope, 63X). The images of 2-cell in <10% uneven and >10% even, and
blastocyst in <10% uneven and <10% even were also used for measuring fluorescence intensity in Figures S3 and S6, respectively.
(C) Statistical comparison of MitoTracker Red distribution in each blastomere of embryos at 2-, 4-, and 8-cell stage and blastocysts. UE, uneven; E, even. Data
are represented as scatterplot with mean G SD. Asterisks indicated significant differences (*p < 0.05, **p < 0.01, Mann-Whitney test). Scale bar, 40 mm.
See also Video S1, Figures S3–S6 and Tables S7–S10.
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When heteroplasmic values are close to the detection limit, technical variability will likely be mixed in with the
biological variability and may contribute to ‘‘segregation’’ as well. However, the spread trend of mtDNA het-
eroplasmy in preimplantation embryo was consistent with recent studies (Johnston et al., 2015; Lee et al.,
2012), suggesing that heteroplasmic values from pyrosequencing are reliable in our study. Our results showed
that uneven inheritance donor mtDNA in embryonic blastomeres rather than selective replication of donor
mtDNA causes the ‘‘segregation’’ in adult tissues of heteroplasmic mice with low level of heteroplasmy.
The spread trend of donor mtDNA heteroplasmy and V0(h) values increases from 2-cell, through 3- to 4-cell,
to 6- to 8-cell blastomeres, evidenced by how the spread trend of 8-cell is greater in turn than that of 4-cell
and 2-cell blastomeres. This phenomenon is consistent with the results of Johnston et al. and Lee et al. studies
(Johnston et al., 2015; Lee et al., 2012). Recent studies showed that mitochondrial concentration is controlled
in the stochastic partition between cell division (Das Neves et al., 2010; Jajoo et al., 2016). Thus the spread
trend could be attributed to how donor mitochondria are randomly assigned into two daughter blastomeres
during mitosis of preimplantation embryos, resulting in much higher uneven inheritance of mtDNA in each
blastomere when cleavage frequency increased, due to how they are stochastically partitioned during cell di-
vision. However, the spread trend in adult tissues almost resumes the initial spread range of the first embryonic
cleavage in this study (Figures 3A–3D). As development progressed to adult stage, each tissue may be devel-
oped from more than one blastomere of an embryo at 8-cell stage, thus leading to the spread trend initiali-
zation, which indicated that no selective replication of donor mtDNA took place during the progressive cleav-
age across developmental stages.
Burgstaller et al. found that mtDNA segregation in heteroplasmic tissues is common in vivo and may be
modulated by haplotype differences (Burgstaller et al., 2014a). Based upon their data (See Methods-Math-
ematical Analysis section), we created a mathematical model and formula that describes the relationship
between the proliferation rate of donor mtDNA and genetic distance. From the formula we can deduce
that when genetic distance (d) of haplotype differences is equal to or less than 9 SNPs, the expected level
of segregation, albeit with substantial uncertainty, drops to zero (Figure S7). Thus, in our study, no segre-
gation is present in tissue of heteroplasmic mice containing two mtDNA genotypes of NZW strain and C57
strain, as the mtDNA genotypes differ at only three SNPs. As mtDNA segregation is controlled by the nu-
clear genome (Agaronyan et al., 2015; Battersby et al., 2003), our results suggest that haplotype matching
matches foreign mitochondrial and nuclear DNA as well, so that the nucleus treats similar mtDNA
sequence the same, thus preventing segregation.
As we know, mtDNA point mutation causes a variety of different phenotypes in humans. The effect of point
mutations on segregation in different tissues during lifetime is still enigmatic. Segregation of somemtDNA
mutations, such as 8993T > G, yield no tissue segregation (White et al., 1999), whereas for others, such as
3243A > G, segregation varies drastically among tissues (Frederiksen et al., 2006). The latter seems to
violate our results and speculation from Burgstaller’s data, in which differences less than 9 SNPs could
circumvent segregation of mutant mitochondria (Figure S7). Owing to a rapidmutation rate over the human
lifetime, a number of novel mtDNAmutations, which constitutes mtDNA polymorphisms, were detected in
both pathogenic mtDNA carriers’ and healthy donors’ oocytes (Kang et al., 2016). Owing to how genetic
distance between two random selected people will differ at 100 SNPs (Røyrvik et al., 2016), previous studies
found that polymorphisms can grant a replicative advantage (Burgstaller et al., 2014b; Kang et al., 2016). It
has been demonstrated that some mtDNA point mutations, such as 3394C variant, may either be delete-
rious or beneficial depending on its haplogroup and environmental context (Ji et al., 2012), suggesting the
segregation of point mutations associated with the polymorphisms. We hypothesize that original polymor-
phisms and novel variations may interact with pathogenic point mutation to constitute a network with
nuclear DNA to regulate mutant and non-mutant mtDNA proliferation. Thus, multiple factors should be
combined and taken into account for the point mutations as well as other mutants on segregation in further
study.
In summary, mitochondrial segregation inevitably occurs in offspring from mitochondrial replacement
manipulation if no haplotype matching has been conducted. This study indicates that genetic similarity
between donor and recipient mtDNA has the potential to circumvent the segregation bias toward patho-
genic maternal mtDNA in tissues of mitochondria replacement offspring. Thus our results recommend that
mtDNA haplotype matching should be undertaken between the donor and recipient, as it could ‘‘fool’’ the
nucleus into treating the donatedmtDNA and the native pathogenic mtDNA the same, thereby eliminating
any proliferative advantage, and circumvent any segregation bias and prevent the onset of mitochondrial
diseases.
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Limitations of the Study
Although this study has demonstrated that matching mtDNA haplotypes could circumvent the tissue
segregation of mutant mitochondria in heteroplasmic mice with 3 SNP difference, more spectra (such as
3–18 SNPs) of mitochondrial genetic differences between two kinds of mice should be conducted to clearly
address the minimum distance that can circumvent tissue segregation. Furthermore, screening key SNP
loci or regulatory networks, which is associated with mtDNA replication and proliferation in nuclear and
mtDNA sequences, may make it easier to find a suitable recipient donation and prevent the occurrence
of mitochondrial diseases.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.isci.2019.03.002.
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Albrechtová, J., Kolbe, T., Vogl, C., Futschik, A.,
Mayrhofer, C., Klein, D., Sabitzer, S., et al. (2014a).
mtDNA segregation in heteroplasmic tissues is
common in vivo and modulated by haplotype
differences and developmental stage. Cell Rep.
7, 2031–2041.
Burgstaller, J.P., Johnston, I.G., and Poulton, J.
(2014b). Mitochondrial DNA disease and
developmental implications for reproductive
strategies. Mol. Hum. Reprod. 21, 11–22.
Carling, P.J., Cree, L.M., and Chinnery, P.F.
(2011). The implications of mitochondrial DNA
copy number regulation during embryogenesis.
Mitochondrion 11, 686–692.
Das Neves, R.P., Jones, N.S., Andreu, L., Gupta,
R., Enver, T., and Iborra, F.J. (2010). Connecting
variability in global transcription rate to
mitochondrial variability. PLoS Biol. 8, e1000560.
Frederiksen, A.L., Andersen, P.H., Kyvik, K.O.,
Jeppesen, T.D., Vissing, J., and Schwartz, M.
(2006). Tissue specific distribution of the 3243A-
>G mtDNA mutation. J. Med. Genet. 43,
671–677.
Graven, L., Tuppen, H.A., Greggains, G.D.,
Harbottle, S.J., Murphy, J.L., Cree, L.M.,
Murdoch, A.P., Chinnery, P.F., Taylor, R.W.,
Lightowlers, R.N., et al. (2010). Pronuclear transfer
in human embryos to prevent transmission of
mitochondrial DNA disease. Nature 465, 82–85.
He, Y., Wu, J., Dressman, D.C., Iacobuzio-
Donahue, C., Markowitz, S.D., Velculescu, V.E.,
Diaz, L.A., Jr., Kinzler, K.W., Vogelstein, B., and
Papadopoulos, N. (2010). Heteroplasmic
mitochondrial DNA mutations in normal and
tumour cells. Nature 464, 610–614.
Hyslop, L.A., Blakeley, P., Craven, L., Richardson,
J., Fogarty, N.M., Fragouli, E., Lamb, M.,
Wamaitha, S.E., Prathalingam, N., Zhang, Q.,
et al. (2016). Towards clinical application of
pronuclear transfer to prevent mitochondrial
DNA disease. Nature 534, 383–386.
Jajoo, R., Jung, Y., Huh, D., Viana, M.P., Rafelski,
S.M., Springer, M., and Paulsson, J. (2016).
Accurate concentration control of mitochondria
and nucleoids. Science 351, 169–172.
Jenuth, J.P., Peterson, A.C., and Shoubridge, E.A.
(1997). Tissue-specific selection for different
mtDNA genotypes in heteroplasmic mice. Nat.
Genet. 16, 93–95.
378 iScience 13, 371–379, March 29, 2019
Ji, F., Sharpley, M.S., Derbeneva, O., Alves, L.S.,
Qian, P., Wang, Y., Chalkia, D., Lvova, M., Xu, J.,
Yao, W., et al. (2012). Mitochondrial DNA variant
associated with Leber hereditary optic
neuropathy and high-altitude Tibetans. Proc.
Natl. Acad. Sci. U S A 109, 7391–7396.
Johnston, I.G., and Jones, N.S. (2015). Closed-
form stochastic solutions for non-equilibrium
dynamics and inheritance of cellular components
over many cell divisions. Proc. Math. Phys. Eng.
Sci. 471, 20150050.
Johnston, I.G., and Jones, N.S. (2016). Evolution
of cell-to-cell variability in stochastic, controlled,
heteroplasmic mtDNA populations. Am. J. Hum.
Genet. 99, 1150–1162.
Johnston, I.G., Burgstaller, J.P., Havlicek, V.,
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Figure S1. Schematic charts of this study hypothesis: Phylogenetic tree hypothesizes the 
correlation between tissue segregation of mtDNA and mitochondrial genetic distance, 
Related to Figure 1. 
(A) Segregation increases with the genetic distance between ‘‘donor’’ and ‘‘recipient’’ mtDNA 
haplotypes. * Referred to Burgstaller et al. Cell Reports 7, 2031–2041, 2014. (B) Hypothesis of 
this study: shortening genetic distance between “donor” and “recipient” can circumvent the 
segregation of pathogenic maternal mtDNA. (C) Experiments of this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2. Standard curves for the pyrosequencing assay, Related to Figures 1, 2 and 
Transparent Methods 
(A) Linear relationship between the actual heteroplasmy values and expected heteroplasmy 
values of SNP "C". (B) Linear relationship between the actual heteroplasmy values and expected 
heteroplasmy values of SNP "T". The lowest reliable level of heteroplasmy detection is 1%. Each 
data point indicates the mean of triplicate samples. 
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Figure S3. Tracking donor mtDNA distribution in embryos at 2-cell stage, Related to Figure 4 
(A) Uneven distribution of donor mtDNA in embryos at 2-cell stage from heteroplsmic oocytes 
with <10% donor mtDNA. (B) Even distribution of donor mtDNA in embryos at 2-cell stage from 
heteroplsmic oocytes with <10% donor mtDNA. (C) Even distribution of donor mtDNA in 
embryos at 2-cell stage from heteroplsmic oocytes with >10% donor mtDNA. The fourth image 
in (A) and the third image in (C) (count by row) was also presented in Figure 4B to demonstrate 
the living cell staining experiment. Scale bar, 40 μm. 
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Figure S4. Tracking donor mtDNA distribution in embryos at 4-cell stage, Related to Figure 4 
(A) Uneven distribution of donor mtDNA in embryos at 4-cell stage from heteroplsmic oocytes 
with <10% donor mtDNA. (B) Even distribution of donor mtDNA in embryos at 4-cell stage from 
heteroplsmic oocytes with <10% donor mtDNA. (C) Even distribution of donor mtDNA in 
embryos at 4-cell stage from heteroplsmic oocytes with >10% donor mtDNA. Scale bar, 40 μm. 
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Figure S5. Tracking donor mtDNA distribution in embryos at 8-cell stage, Related to Figure 4 
(A) Uneven distribution of donor mtDNA in embryos at 8-cell stage from heteroplsmic oocytes 
with <10% donor mtDNA. (B) Even distribution of donor mtDNA in embryos at 8-cell stage from 
heteroplsmic oocytes with <10% donor mtDNA. (C) Even distribution of donor mtDNA in 
embryos at 8-cell stage from heteroplsmic oocytes with >10% donor mtDNA. Scale bar, 40 μm. 
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Figure S6. Tracking donor mtDNA distribution in blastocysts, Related to Figure 4 
(A) Uneven distribution of donor mtDNA in blastocysts from heteroplsmic oocytes with <10% 
donor mtDNA. (B) Even distribution of donor mtDNA in blastocysts from heteroplsmic oocytes 
with <10% donor mtDNA. (C) Even distribution of donor mtDNA in blastocysts from 
heteroplsmic oocytes with >10% donor mtDNA. The fourth image in (A) and the second image in 
(C) (count by row) was also presented in Figure 4B to demonstrate the living cell staining 
experiment. Scale bar, 40 μm. 
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Figure S7. Correlation of proliferation rate of wild-derived mtDNA and genetic distance, 
Related to Figures 1-4. 
The proliferation rate increases as genetic distance of haplotypes rises based on past data 
(Burgstaller et al., 2014). When the genetic distance is less than 9 SNPsthe anticipated mean of 
proliferation rate equals to 0. Regression curve and shaded region (red) show curve model fit and 
95% confidence intervals.  
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Supplemental Tables 
 
Table S1. Nucleotide differences between B6D2F1(C57/BL6×DBA) and NZW/Lac J mitochondrial DNA, Related to Figures 1, 2 and 
Transparent Methods. 
Genes Polymorphism Sequences 
ND3 C9461T Query 9421 TCCAATTAGTAGATTCTGAATAAACCCAGAAGAGAGTAATCAACCTGTACACTGTTATCT 9480 
 Sbjct 9421 TCCAATTAGTAGATTCTGAATAAACCCAGAAGAGAGTAATTAACCTGTACACTGTTATCT 9480 
tRNA-Arg A9821- Query 9781 AAAAAGGATTAGAATGAACAGAGTAAATGGTAATTAGTTTAAAAAAAAATTAATGATTTC 9840 
Sbjct 9781 AAAAAGGATTAGAATGAACAGAGTAAATGGTAATTAGTTT-AAAAAAAATTAATGATTTC 9839 
ND5 C13053T Query 13021 ATTTACTTCGTAACAATAACAAAACCGCGTTTCCCCCCCCTAATCTCCATTAACGAAAAT 13080 
 Sbjct 13020 ATTTACTTCGTAACAATAACAAAACCGCGTTTTCCCCCCCTAATCTCCATTAACGAAAAT 13079 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S2. Primer sequences and conditions of PCR for mitochondria genome (nucleotide 
position, 9201-11102) amplification, Related to Figures 1, 2 and Transparent Methods. 
Primary PCR 
 
   
 Conditions 
5’-ATGGCTACTGGATTCCATGG-3’ 
3’- GCTCCTATGAAGCTTCATGG-5’ 
 
95°C for 3 min;  
40 cycles with denaturation at 94°C for 30 s, annealing at 59°C for 
30 s, and elongation at 72°C for 1 min;  
1 cycle at 72°C for 7 min;  
hold at 4°C 
  
Second round PCR 
 
     
 Conditions 
5’-TTTGAAGCCGCAGCATGA-3’ 
3’-ATTTATTTGGGGGAGTCAGAATGC-5’ 
 
95°C for 3 min,  
40 cycles with denaturation at 94°C for 30 s, annealing at 53°C for 
30 s, and elongation at 72°C for 1 min;  
1 cycle at 72°C for 7 min;  
hold at 4°C 
  
 
 
 
 
  
 
 
 
 
 
Table S3. Heteroplasmy in adult tissues, Related to Figures 1and 3. 
	
Mouse 
Donor mtDNA (%) in adult tissues Mean (%) S.D.
 V'(h) Range (%) 
Brain Heart Lung Liver Kidney Stomach Intestine Spleen Muscle Adipose Skeleton Bladder Gonad Hypoth- alamus 
Optic 
Nerve Skin    
 
1 0 2.71 0 3.15 0 3.66 0 0 0 3.81 0 2.2 2.88 0 0 11.29 1.86 0.03 0.0478 11.29 
2 6.21 0 6.49 0 0 0 7.16 4.45 2.9 5.66 0 6.36 0 6.96 0 6.13 3.27 0.03 0.0311 7.16 
3 0 6.6 4.43 6.13 4.62 6.15 4.32 5.23 4.77 6.6 4.57 5.91 5.44 5.13 6.26 0 4.76 0.02 0.0089 6.60 
4 7.67 0 7.58 0 7.69 0 7.29 5.63 4.95 7.05 6.73 7.33 4.94 7.4 5.68 5.96 5.37 0.03 0.0156 7.69 
5 7.32 7.02 0 0 8.02 6.97 9.17 5.43 8.49 8.11 7.68 7.22 5.17 7.81 5.28 7.11 6.30 0.03 0.0124 9.17 
6 5.58 6.28 4.62 6.43 7.56 7.05 6.12 6.3 6.6 6.14 7.04 5.89 6.06 6.32 6.13 6.78 6.31 0.01 0.0008 2.94 
7 8.67 0 8.13 0 8.52 5.48 8.46 6.29 6.53 8.33 6.29 9.16 6.04 9.17 6.48 7.1 6.54 0.03 0.0130 9.17 
8 6.85 6.65 6.16 6.28 6.89 5.48 6.18 7.58 5.91 7.28 6.77 7.19 6.73 6.58 8.19 6.87 6.72 0.01 0.0007 2.71 
9 5.62 8.73 6.6 7.61 7.4 7.16 0 0 9.31 6.29 9.08 7.05 9.71 8.53 7.94 7.32 6.77 0.03 0.0131 9.71 
10 9.07 0 9.23 8.58 8.46 0 8.53 5.8 9.21 8.35 6.27 8.13 6.95 8.93 6.72 7.58 6.99 0.03 0.0132 9.23 
11 9.37 5.94 8.8 5.91 8.77 5.49 6.89 6.2 7.43 7.48 6.67 8.69 4.88 7.91 5.93 8.35 7.17 0.01 0.0028 4.49 
12 6.53 7.89 5.81 8.56 7.21 8.63 5.63 8.51 7.94 11.04 7.2 8.11 8.73 7.21 7.76 7.19 7.75 0.01 0.0023 5.41 
13 7.58 9.7 6.43 7.9 8.68 6.52 8.74 6.35 9.68 6.29 9.02 8.42 8.77 8.31 8.41 10.18 8.19 0.01 0.0021 3.89 
14 8.82 10.28 9.08 9.48 8.26 11.47 8.22 10.76 8.54 10.89 9.28 10.19 10.56 9.34 10.28 10.6 9.75 0.01 0.0012 3.25 
15 8.43 9.96 9.71 10.82 9.89 12.35 12.96 10.85 10.3 11.35 11.71 7.87 9.74 9.48 10.14 1.94 9.84 0.02 0.0070 11.02 
16 10.58 9.81 10.89 8.75 9.33 9.99 9.32 10.08 10.77 10.85 9.32 10.16 9.09 9.26 10.62 10.65 9.97 0.01 0.0006 2.14 
17 11.18 9.47 10.08 9.77 11.23 7.82 12.68 9.84 9.12 11.67 11.06 12.06 7.85 11.26 8.82 13.08 10.44 0.02 0.0027 5.26 
18 10.54 13.33 11.6 13.38 12.17 10.86 14.34 11.78 13.41 11.34 12.04 11.63 12.7 11.65 12.5 11.17 12.15 0.01 0.0010 3.80 
19 12.06 12.18 11.75 14.36 12.68 11.25 14.81 12.56 12.96 12.88 14.03 11.03 15.03 14.6 13.02 10.21 12.84 0.01 0.0018 4.82 
20 14.99 11.9 15.12 10.83 13.84 10.48 14.02 11.85 13.96 15.61 12.38 15.12 12.24 14.04 11.67 11.81 13.12 0.02 0.0024 5.13 
21 15.19 14.63 13.61 10.79 14.4 9.61 13.89 12.5 13.28 12.68 12.6 13.14 12.45 14.42 13.62 16.36 13.32 0.02 0.0023 6.75 
22 13.71 13.37 14.69 12.46 15.19 11.97 14.43 13.72 11.95 13.86 12.29 15.03 11.18 15.74 11.94 14.39 13.50 0.01 0.0016 4.56 
23 15.68 14.45 15.66 11.47 15.34 13.22 15.58 14.37 16.69 15.71 14.79 16.49 15.4 16.45 13.24 17.09 15.10 0.01 0.0017 5.62 
24 14.23 16 15 16.38 14.87 13.33 14.71 12.37 15.47 13.16 16.76 15.46 17.76 15.68 15.51 16.67 15.21 0.01 0.0016 5.39 
25 15.32 15.9 14.48 14 14.42 17.34 14.56 15.57 13.92 15.38 15.45 16.69 16.9 14.66 15.21 15.33 15.32 0.01 0.0008 3.42 
26 14.93 16.68 14.36 13.73 16.79 15.9 15.03 15.74 17.14 14.6 16.85 15.46 16.89 15.89 17.32 15.06 15.77 0.01 0.0009 3.59 
27 16.62 19.69 17.74 16.46 17.53 17.68 18.92 17.33 17.25 17.58 19.03 18.98 19.02 19.93 18.37 16.93 18.07 0.01 0.0008 3.47 
28 21.24 20.76 23.06 17.67 20.71 21.88 23.19 19.06 19.14 20.73 20.38 19.76 18.42 21.38 18.55 21.9 20.49 0.02 0.0016 5.52 
29 19.91 21.99 21.29 23.08 23.94 18.38 25.25 20.39 21.26 19.3 22.02 21.65 22.76 21.75 23.28 15.81 21.38 0.02 0.0031 9.44 
30 21.58 21.38 22.58 20.83 20.44 21.63 21.66 22.1 21.87 23.86 21.4 22.56 22.55 19.13 21.87 21.94 21.71 0.01 0.0006 4.73 
31 23.64 25.23 24.62 22.35 25.8 24.68 24.42 23.84 26.53 24.86 21.92 23 24 21.78 24.7 17.87 23.70 0.02 0.0023 8.66 
32 24.14 24.22 26.75 22.79 27.03 23.91 24.93 22.59 25.19 23.52 23.06 23.22 21.92 24.1 22.02 25.26 24.04 0.02 0.0012 5.11 
33 24.3 27.65 25.87 26.5 26.72 23.97 24.95 24.48 23.23 24.86 24.11 24.01 24.44 21.89 23.68 22.48 24.57 0.02 0.0013 5.76 
34 27.33 27.69 26.11 25.77 29.92 28.17 27.99 26.05 27.02 25.81 25.35 26.32 23.94 28.21 26.55 26.04 26.77 0.01 0.0010 5.98 
35 32.54 33.41 31.53 34.13 32.01 34 32.58 33.91 32.94 28.67 33.46 33.89 33.49 32.36 33.82 35.58 33.02 0.02 0.0010 6.91 
36 35.71 33.56 33.57 32.39 36.79 32.72 36.72 32.23 36.15 32.31 36.23 36.85 35.31 34.27 36.31 34.81 34.75 0.02 0.0013 4.62 
37 39.3 40 37.37 40.72 35.73 41.9 36.39 39.04 33.79 37.16 36.58 39.05 39.28 39.01 38.91 35.91 38.13 0.02 0.0019 8.11 
Mean 14.39 14.19 14.35 13.50 14.83 13.71 14.87 13.80 14.48 14.62 14.31 14.90 14.30 14.77 14.24 14.34 14.35 0.02 0.0056 6.01 
S.D., standard deviation; V'(h), normalised variance; Range, differences between maximum and minimum values among 16 adult tissues. 
 
	
	
Table S4. Heteroplasmy in blastomeres of 2 cell embryos, Related to Figures 2and 3. 
Embryo 
Donor mtDNA (%) in 
blastomeres Mean (%) S.D. V'(h) Range (%) 
1 2 
1 3.89 0.00 1.95 0.02 0.0198 3.89 
2 5.86 0.00 2.93 0.03 0.0302 5.86 
3 6.04 0.00 3.02 0.03 0.0311 6.04 
4 2.23 4.71 3.47 0.01 0.0046 2.48 
5 4.16 4.92 4.54 0.00 0.0003 0.76 
6 8.74 6.08 7.41 0.01 0.0026 2.66 
7 5.58 9.97 7.78 0.02 0.0067 4.39 
8 9.52 10.05 9.79 0.00 0.0001 0.53 
9 10.93 8.79 9.86 0.01 0.0013 2.14 
10 8.79 12.53 10.66 0.02 0.0037 3.74 
11 15.39 15.39 15.39 0.00 0.0000 0.00 
12 14.88 16.09 15.49 0.01 0.0003 1.21 
13 15.24 15.91 15.58 0.00 0.0001 0.67 
14 16.85 14.45 15.65 0.01 0.0011 2.40 
15 23.41 8.91 16.16 0.07 0.0388 14.50 
16 18.66 16.38 17.52 0.01 0.0009 2.28 
17 18.99 16.74 17.87 0.01 0.0009 2.25 
18 19.88 20.58 20.23 0.00 0.0001 0.70 
19 23.05 20.56 21.81 0.01 0.0009 2.49 
20 23.05 20.56 21.81 0.01 0.0009 2.49 
21 21.80 26.14 23.97 0.02 0.0026 4.34 
22 26.86 24.23 25.55 0.01 0.0009 2.63 
23 25.22 27.33 26.28 0.01 0.0006 2.11 
24 27.84 28.06 27.95 0.00 0.0000 0.22 
25 29.10 28.52 28.81 0.00 0.0000 0.58 
26 37.43 41.82 39.63 0.02 0.0020 4.39 
S.D., standard deviation; V'(h), normalised variance; Range, differences between maximum and 
minimum values in daughter blastomeres. 
 
Table S5. Heteroplasmy in blastomeres of 3-4 cell embryos, Related to Figures 2 and 3. 
Embryo 
Donor mtDNA (%) in blastomeres 
Mean (%) S.D. V'(h) Range (%) 
1 2 3 4 
1 0.00 3.71 0.00 3.51 1.81 0.02 0.0184 3.71 
2 3.99 0.00 3.24 0.00 1.81 0.02 0.0188 3.99 
3 0.00 3.85 0.00 3.53 1.85 0.02 0.0189 3.85 
4 3.12 0.00 4.86 0.00 2.00 0.02 0.0223 4.86 
5 4.86 0.00 3.77 0.00 2.16 0.02 0.0228 4.86 
6 5.69 0.00 0.00 4.63 2.58 0.03 0.0270 5.69 
7 9.21 0.00 0.00 2.14 2.84 0.04 0.0519 9.21 
8 6.17 0.00 5.55 0.00 2.93 0.03 0.0304 6.17 
9 3.88 3.16 3.55 3.20 3.45 0.00 0.0003 0.72 
10 5.51 4.77 5.08 0.00 3.84 0.02 0.0135 5.51 
11 5.21 0.00 3.93 6.60 3.94 0.02 0.0160 6.60 
12 4.51 4.18 4.06 5.50 4.56 0.01 0.0007 1.44 
13 7.41 5.60 6.74 0.00 4.94 0.03 0.0182 7.41 
14 6.95 6.91 7.88 5.21 6.74 0.01 0.0015 2.67 
15 4.42 12.00 5.24 8.14 7.45 0.03 0.0128 7.58 
16 11.46 9.68 12.70 0.00 8.46 0.05 0.0323 12.70 
17 8.60 9.67 6.65 9.55 8.62 0.01 0.0019 3.02 
18 9.83 7.41 9.66 8.82 8.93 0.01 0.0011 2.42 
19 8.39 10.72 7.60 11.50 9.55 0.02 0.0030 3.90 
20 11.25 10.20 8.54 8.50 9.62 0.01 0.0016 2.75 
21 12.13 7.29 10.46 9.81 9.92 0.02 0.0034 4.84 
22 10.52 8.07 11.72 10.98 10.32 0.01 0.0020 3.65 
23 11.52 8.90 12.15 9.32 10.47 0.01 0.0021 3.25 
24 12.65 14.00 9.52 9.75 11.48 0.02 0.0036 4.48 
25 10.99 12.21 12.29 11.44 11.73 0.01 0.0003 1.30 
26 13.98 13.94 11.81 NA 13.24 0.01 0.0009 2.17 
27 14.95 10.79 14.14 14.86 13.69 0.02 0.0024 4.16 
28 13.14 13.76 15.16 15.08 14.29 0.01 0.0006 2.02 
29 14.56 14.03 14.42 14.72 14.43 0.00 0.0001 0.69 
30 14.51 14.77 14.88 NA 14.72 0.00 0.0000 0.37 
31 9.94 16.07 17.84 15.91 14.94 0.03 0.0070 7.90 
32 15.94 17.26 14.24 NA 15.81 0.01 0.0011 3.02 
33 15.35 16.68 16.33 16.81 16.29 0.01 0.0002 1.46 
34 19.22 16.09 15.85 18.64 17.45 0.01 0.0016 3.37 
35 17.19 20.44 17.33 NA 18.32 0.02 0.0015 3.25 
36 21.89 22.20 19.28 21.59 21.24 0.01 0.0008 2.92 
37 21.59 23.76 20.86 24.63 22.71 0.02 0.0013 3.77 
38 22.40 24.94 23.24 22.01 23.15 0.01 0.0007 2.93 
39 27.86 24.13 25.89 29.14 26.76 0.02 0.0019 5.01 
40 22.63 33.66 33.71 NA 30.00 0.05 0.0129 11.08 
41 56.28 50.94 54.14 53.23 53.65 0.02 0.0015 5.34 
42 54.39 50.12 55.90 56.53 54.24 0.02 0.0025 6.41 
S.D, standard deviation; CV, coefficient of variation; Range, differences between maximum and 
minimum values in daughter blastomeres; NA, none applicable. 
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Table S6. Heteroplasmy in blastomeres of 6-8 cell embryos, Related to Figures 2 and 3. 
Embryo 
 Donor mtDNA (%) in blastomeres 
Mean (%) S.D. V'(h) Range (%) 1 2 3 4 5 6 7 8 
1 4.25 0 4.79 0 3.5 0 3.29 4.7 2.57 0.02 0.0167 4.79 
2 4.54 8.83 0.00 6.90 0.00 3.21 0.00 1.90 3.17 0.03 0.0324 8.83 
3 3.85 7.67 6.68 3.57 3.66 0 2.79 1.76 3.75 0.02 0.0149 7.67 
4 0 0 0 3.81 7.46 8.7 5.59 5.08 3.83 0.03 0.0290 8.70 
5 21.04 0 3.8 0 0 0 NA NA 4.14 0.08 0.1488 21.04 
6 0 0.00 0.00 2.97 0.00 3.10 3.17 39.83 6.13 0.13 0.2853 39.83 
7 7.42 5.69 6.59 5.27 6.08 5.93 7.12 5.24 6.17 0.01 0.0010 2.18 
8 10.92 0 7.34 0 11.78 5.69 8.24 8.19 6.52 0.04 0.0285 11.78 
9 6.75 7.80 6.34 7.06 9.10 6.92 10.02 NA 7.71 0.01 0.0022 3.68 
10 8.96 9.59 7.28 10.6 7.33 9.37 7.47 NA 8.66 0.01 0.0019 3.32 
11 5.75 7.73 6.33 8.76 12.54 11.08 14.15 7.28 9.20 0.03 0.0098 8.40 
12 7.11 9.21 12.77 12.97 5.15 11.98 NA NA 9.87 0.03 0.0099 7.82 
13 15.49 8.13 8.63 16.99 7.61 5.49 7.27 NA 9.94 0.04 0.0188 11.50 
14 8.69 8.36 11.03 8.96 11.65 9.81 10.72 11.37 10.07 0.01 0.0016 3.29 
15 18.62 20.95 11.41 6.55 5.59 5.11 NA NA 11.37 0.06 0.0397 15.84 
16 8.13 11.01 6.58 9.26 3.97 12.68 22.66 25.32 12.45 0.07 0.0467 21.35 
17 13.95 12.35 12.82 13.84 13.76 12.99 12.32 12.34 13.05 0.01 0.0004 1.63 
18 16.93 8.46 12.81 13.43 14.14 14.71 11.98 14.17 13.33 0.02 0.0045 8.47 
19 12.84 15.03 17.72 16.17 14.37 16.07 15.32 21.30 16.10 0.02 0.0042 8.46 
20 11.42 12.90 37.15 11.67 14.84 13.27 12.91 NA 16.31 0.09 0.0538 25.73 
21 20.79 19.75 19.19 18.59 14.96 15.09 15.37 12.94 17.09 0.03 0.0050 7.85 
22 17.46 15.58 16.81 16.18 17.81 19.19 NA NA 17.17 0.01 0.0010 3.61 
23 18.18 21.37 18.56 16.3 18.6 17.07 15.92 NA 18 0.02 0.0019 5.45 
24 12.06 29.32 19.8 14.68 22.81 22.12 24.61 15.88 20.16 0.05 0.0178 17.26 
25 21.16 27.53 20.11 22.74 23.09 22.51 20.3 28.19 23.20 0.03 0.0047 8.08 
26 29.51 32.13 27.42 28.24 26.86 28.11 25.35 NA 28.23 0.02 0.0020 6.78 
27 29.25 33.07 27.62 29.24 27.64 31.90 29.92 19.12 28.47 0.04 0.0077 13.95 
28 33.84 38.34 34.65 34.17 36.28 34.54 35.97 37.34 35.64 0.02 0.0010 4.50 
29 36.33 47.29 37.67 33.27 34 33.25 NA NA 36.97 0.05 0.0103 14.04 
30 35.13 34.98 37.57 36.67 39.36 37.55 38.19 NA 37.06 0.01 0.0009 4.38 
31 47.09 37.87 41.8 38.35 42.21 44.99 39.29 NA 41.66 0.03 0.0042 9.22 
32 49.7 41.29 50.21 44.04 46.5 44.37 45.76 NA 45.98 0.03 0.0035 8.92 
33 51.34 50.6 51.45 51.56 52.15 54.36 NA NA 51.91 0.01 0.0006 3.76 
S.D, standard deviation; CV, coefficient of variation; Range, differences between maximum and minimum values in daughter 
blastomeres; NA, none applicable. 
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Table S7. Fluorescence intensity in blastomeres of 2 cell embryos, Related to Figure 4. 
 
Proportion 
of 
mitotracker 
Embryo 
Fluorescence intensity in 
blastomeres 
 Proportion 
Variance  
1 2  1 2 
<10% 
uneven 
1 44770 7297  0.86 0.14 0.0198 
2 7302 3887  0.65 0.35 0.0302 
3 27181 0  1.00 0.00 0.0311 
4 170043 32531  0.84 0.16 0.0046 
5 76730 16188  0.83 0.17 0.0003 
        
<10% 
even 
1 35819 33211  0.52 0.48 0.0026 
2 29913 14320  0.68 0.32 0.0067 
3 17629 29768  0.37 0.63 0.0001 
4 54076 49367  0.52 0.48 0.0013 
5 30674 33145  0.48 0.52 0.0037 
6 92391 104795  0.47 0.53 0.0000 
        
>10% 
1 147731 106206  0.58 0.42 0.0003 
2 233691 174094  0.57 0.43 0.0001 
3 190303 260991  0.42 0.58 0.0011 
4 592428 338429  0.64 0.36 0.0388 
5 1422731 2361465  0.38 0.62 0.0009 
6 1359749 672487  0.67 0.33 0.0009 
Proportion, the ratio of each blastomere fluorescence intensity to total intensity; variance, 
variance of proportion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S8. Fluorescence intensity in blastomeres of 4 cell embryos, Related to Figure 4. 
 
Proportion 
of 
mitotracker 
Embryo 
Fluorescence intensity in 
blastomeres 
 Proportion 
Variance  
1 2 3 4  1 2 3 4 
<10% 
uneven 
1 150041 128995 0 70537  0.43 0.37 0.00 0.20 0.0278 
2 8448 2662 66156 44323  0.07 0.02 0.54 0.36 0.0461 
3 25738 153750 181180 94722  0.06 0.34 0.40 0.21 0.0172 
4 4180 0 26384 41607  0.06 0.00 0.37 0.58 0.0548 
5 13082 57861 4806 3752  0.16 0.73 0.06 0.05 0.0782 
            
<10% 
even 
1 24502 38983 10516 69138  0.17 0.27 0.07 0.48 0.0230 
2 66231 44487 28675 41905  0.37 0.25 0.16 0.23 0.0055 
3 114208 44697 102938 39832  0.38 0.15 0.34 0.13 0.0123 
4 33237 46103 33116 42960  0.21 0.30 0.21 0.28 0.0014 
5 28904 48390 113791 39221  0.13 0.21 0.49 0.17 0.0208 
6 88670 107586 111489 95982  0.22 0.27 0.28 0.24 0.0005 
            
>10% 
1 590333 638842 579461 806561  0.23 0.24 0.22 0.31 0.0012 
2 335749 290522 267510 231713  0.30 0.26 0.24 0.21 0.0011 
3 232264 263602 290182 312649  0.21 0.24 0.26 0.28 0.0007 
4 185487 151531 414783 391565  0.16 0.13 0.36 0.34 0.0107 
5 648333 1015563 368786 522352  0.25 0.40 0.14 0.20 0.0088 
Proportion, the ratio of each blastomere fluorescence intensity to total intensity; variance, variance of 
proportion. 
 
Table S9. Fluorescence intensity in blastomeres of 6-8 cell embryos, Related to Figure 4. 
 
Proportion 
of 
mitotracker 
Embryo 
Fluorescence intensity in blastomeres              Proportion 
Variance 
1 2 3 4 5 6 7 8  1 2 3 4 5 6 7 8 
<10% 
uneven 
1 3039 3698 1537 9627 25819 8369 4377 1355  0.05 0.06 0.03 0.17 0.45 0.14 0.08 0.02 0.0171 
2 24950 1618 2611 28760 0 6518 1116 5436  0.35 0.02 0.04 0.41 0.00 0.09 0.02 0.08 0.0224 
3 0 0 10006 14533 73739 56436 7347 77209  0.00 0.00 0.04 0.06 0.31 0.24 0.03 0.32 0.0170 
4 14540 19066 7499 22147 13967 13924 0 0  0.16 0.21 0.08 0.24 0.15 0.15 0.00 0.00 0.0071 
5 40895 1619 3880 22006 6828 2726 11442 0  0.46 0.02 0.04 0.25 0.08 0.03 0.13 0.00 0.0213 
6 14468 50243 10369 39879 26394 45449 6960 24044  0.01 0.22 0.03 0.23 0.17 0.04 0.23 0.07 0.0082 
                    
<10% 
even 
1 1636 38848 5745 40990 31144 6836 41016 12283  0.31 0.11 0.03 0.13 0.30 0.02 0.10 NA 0.0122 
2 34253 22860 44841 45996 11659 54296 20628 72583  0.11 0.07 0.15 0.15 0.04 0.18 0.07 0.24 0.0037 
3 36344 12701 3702 15010 34763 2107 10986 NA  0.16 0.11 0.09 0.04 0.08 0.17 0.12 0.22 0.0028 
4 34253 22860 44841 45996 11659 54296 20628 72583  0.14 0.36 0.07 0.12 0.16 0.16 NA NA 0.0081 
5 32328 22743 18416 8944 16369 34701 23669 44728  0.16 0.10 0.12 0.10 0.20 0.11 0.11 0.11 0.0012 
                    
>10% 
1 14012 35680 6909 12183 15539 15757 NA NA  0.17 0.09 0.10 0.14 0.11 0.16 0.11 0.11 0.0007 
2 115035 68640 83185 75013 144522 77619 76613 75835  0.15 0.13 0.18 0.18 0.21 0.14 NA NA 0.0009 
3 136937 76765 86675 115616 91588 134712 91084 94228  0.12 0.17 0.14 0.09 0.08 0.18 0.23 NA 0.0024 
4 178010 148108 210702 214750 249067 161807 NA NA  0.14 0.08 0.11 0.13 0.14 0.11 0.18 0.09 0.0009 
5 133526 181106 153246 92104 81988 189512 241635 NA  0.13 0.11 0.08 0.10 0.32 0.26 NA NA 0.0083 
6 101428 56838 80342 95025 97152 79724 128508 64966  0.11 0.14 0.10 0.09 0.17 0.07 0.17 0.14 0.0014 
7 118481 107027 75974 92444 305334 245952 NA NA  0.13 0.15 0.09 0.11 0.12 0.09 0.13 0.19 0.0009 
 Proportion, the ratio of each blastomere fluorescence intensity to total intensity; variance, variance of proportion; NA, none applicable. 
	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S10. Fluorescence intensity in regions of blastocyst, Related to Figure 4. 
 
Proportion of 
mitotracker embryo 
    Fluorescence intensity in regions of blastocyst   Proportion 
Variance 
1 2 3 4 5 6 7 8 9 10  1 2 3 4 5 6 7 8 9 10 
<10% 
uneven 
1 0 3419 0 0 0 0 0 0 0 0  0.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0900 
2 0 5555 0 0 0 0 0 4592 4828 8172  0.00 0.24 0.00 0.00 0.00 0.00 0.00 0.20 0.21 0.35 0.0165 
3 0 0 0 0 0 2447 7167 0 0 0  0.00 0.00 0.00 0.00 0.00 0.25 0.75 0.00 0.00 0.00 0.0521 
4 0 0 7753 0 0 1188 0 0 9451 0  0.00 0.00 0.42 0.00 0.00 0.06 0.00 0.00 0.51 0.00 0.0346 
5 7223 5301 0 0 0 0 0 5918 22981 0  0.17 0.13 0.00 0.00 0.00 0.00 0.00 0.14 0.55 0.00 0.0275 
6 7756 0 0 3556 0 23785 0 0 0 0  0.22 0.00 0.00 0.10 0.00 0.68 0.00 0.00 0.00 0.00 0.0418 
                        
<10% 
even 
1 12377 24569 44108 19765 2648 2444 5591 393 7186 0  0.10 0.21 0.37 0.17 0.02 0.02 0.05 0.00 0.06 0.00 0.0125 
2 7303 10915 16585 22295 6898 9332 6742 3854 0 0  0.09 0.13 0.20 0.27 0.08 0.11 0.08 0.05 0.00 0.00 0.0062 
3 23954 18478 0 10546 0 0 10900 7836 23400 2398  0.25 0.19 0.00 0.11 0.00 0.00 0.11 0.08 0.24 0.02 0.0085 
4 0 14054 9787 21325 3070 7415 7877 11165 6195 8866  0.00 0.16 0.11 0.24 0.03 0.08 0.09 0.12 0.07 0.10 0.0039 
5 0 0 20183 46521 1807 9458 0 6461 26690 21930  0.00 0.00 0.15 0.35 0.01 0.07 0.00 0.05 0.20 0.16 0.0120 
                        
>10% 
1 14657 11743 27500 67664 124327 19723 22254 23700 14729 51855  0.04 0.03 0.07 0.18 0.33 0.05 0.06 0.06 0.04 0.14 0.0078 
2 90847 1925 26203 63079 54377 61617 74529 31476 62918 34358  0.18 0.00 0.05 0.13 0.11 0.12 0.15 0.06 0.13 0.07 0.0025 
3 32887 21227 24335 14613 40121 20612 69636 15484 46936 15639  0.11 0.07 0.08 0.05 0.13 0.07 0.23 0.05 0.16 0.05 0.0031 
4 19699 42001 6231 3064 13044 20212 8052 0 20484 2093  0.15 0.31 0.05 0.02 0.10 0.15 0.06 0.00 0.15 0.02 0.0080 
5 23139 20390 173049 186452 23889 1991 55685 18418 82425 59600  0.04 0.03 0.27 0.29 0.04 0.00 0.09 0.03 0.13 0.09 0.0092 
 Proportion, the ratio of each blastomere fluorescence intensity to total intensity; variance, variance of proportion. 
	
Transparent Methods  
 
Animals breeding scheme and ethics statement 
   Mitochondria replacement founders were generated from our lab between female NZW/LacJ 
(NZW) and female BDF1 from C57/BL6×DBA (C57) during the past study (Wang et al., 2014). 
Then the female founders were mated with male mice (BDF1) to reproduce heteroplasmic mice 
for this study. All mice used in this study were maintained in accordance with the guidelines of 
the Laboratory Animal Service, Fudan University (research license 20160225-103).  
 
Generation of heteroplasmic standard samples 
   Whole genomic DNA of C57 and NZW were extracted from liver. Then the region of 
mitochondria genome (nucleotide position, 9201-11102) was amplified using primers of primary 
PCR and condition in Table S2. PCR products were cloned using the pMD18-T Vector System 
(Takara) according to the manufacturer's instructions. Plasmid DNA was isolated using QIAGEN 
Plasmid Kit. The DNA concentration was determined by Quantitative real-time PCR using ViiA 7 
Real-Time PCR System (Applied Biosystems) with primers of primary PCR and condition in Table 
S2. Equimolar concentrations of mtDNA with C57 and NZW genotypes were combined in 
varying ratios to generate gradient standard samples, ranging from 0 to 25%.  
 
Genotyping of donor mtDNA Heteroplasmy Level of embryonic blastomeres and adult 
tissues 
   Zona pellucida of embryos at 2-cell, 4-cell, and 8-cell stage was digested by brief exposure to 
0.5% of pronase (Roche, 70229227), 37°C, 5min. Then blastomeres of the denuded embryos 
were disaggregated by brief exposure to trypsin-EDTA, 37°C, 5min. The single blastomere was 
lysised into a 0.2 ml PCR tube containing 4 μl of PBS. Add 3 μl buffer D2 and incubate at 65 °C 
for 10 min, followed by adding 3 μl stop solution. Then whole genomic DNA from single 
blastomere was amplified using REPLI-g Single Cell Kit (QIAGEN, 150345). 
   Whole genomic DNA of heteroplasmic mice (6~8 months old) were isolated using DNA 
extracted from brain, heart, lung, liver, spleen, bone, bladder, gonad, pituitary, skin, optic nerve, 
stomach, intestine, fat, muscle, and kidney using Genomic DNA Kit (Tiangen).  
   To determine the distribution of donor mtDNA in pre-implanted embryos and adult tissues, 
the region of mice mitochondria genome (nucleotide position, 9201-11102) was amplified from 
total genome of single blastomere and tissue using the primary PCR. The primer sequences and 
conditions were seen in Table S2. PCR was performed using ABI cycler. The SNP used for 
detecting heteroplasmy is m.9461C>T (Table S1) and confirmed by pyrosequencing. Detailed 
methods for pyrosequencing were processed according to the previously described methods 
(Wang et al., 2014). The second round PCR sequences and conditions were seen in Table S2. 
Single-stranded biotinylated PCR products were prepared for sequencing by Pyrosequencing 
Vacuum Prep Tool (Biotage AB) according the protocol of PyroMark Q96 ID platform (Qiagen). 
Primer used for pyrosequencing was 5’-GAATAAACCCAGAAGAGAGT-3’. Quantification of the 
donor mtDNA heteroplasmy level of variant m.9461C>T was performed using allele frequency 
quantification (AQ) function in PyroQ-AQ software (Wang et al., 2014). A standard curve was 
generated by linking expected heteroplasmy values and actual heteroplasmy values for the 
gradient standard samples. 
     
Mathematical analysis to predict the genetic distance related to segregation 
The mathematical model was created to describe the relationship between the proliferation rate 
of donor mtDNA (calculated as mean of absolute inferred wild-derived proliferation rate) and 
genetic distance based upon past data (Burgstaller et al., 2014a). Logarithmic fitting on their 4 
sets of data was performed to get the following expression:  
 
r was defined as the mean proliferation rate of donor mtDNA and d as the genetic distance 
(SNPs) of mtDNA between haplotypes. This model is used to find the maximum genetic distance 
before segregation bias takes effect and predict the proliferation rate at a certain genetic 
distance (Figure S7). 
 
Heteroplasmic oocytes construction by spindle-chromosome complex transfer (spindle 
transfer) 
   The lyophilized MitoTracker Red CMXRos (M7512, Life Technology) was dissolved in 
high-quality, anhydrous dimethylsulfoxide (DMSO) to a final concentration of 1 mM to prepare a 
stock solution. Then stock solution was diluted to 250nM concentration (working solution) in G1 
medium. Donor mouse oocytes were dyed with 250nM MitoTracker. Then Spindle-chromosome 
complex with different amount of red mitochondria were transferred into enucleated oocyte 
containing unstained mitochondria (Wang et al., 2014). All manipulations were performed on a 
37 °C -heated stage (Tokai Hit) of a Nikon TE 2000S inverted microscope equipped with 
Narishige micromanipulators, a laser objective and an OosightTM Imaging System. Stained 
oocytes and unstained oocytes were placed into manipulation droplets of G-gamete containing 
CB in a glass-bottom dish. 
   An unstained oocyte was suctioned with the holding pipette, so that the spindle was located 
in the 3 o’clock position. The zona pellucida close to the spindle was drilled with a laser, and an 
enucleation pipette was then inserted through the hole in the zona pellucida. The spindle was 
enucleated with a minimal amount of red mitochondria, and the enucleated oocyte was released 
into manipulation medium. Then the spindle-chromosome complex of stained oocyte was 
enucleated as the same to the unstained oocyte with a diameter of 12 μm pipette and then 
transferred to the HVJ-E (inactivated Hemagglutinating Virus of Japan envelope, GenomeOne, 
Cosmo Bio) drop for brief exposure. The enucleated spindle-chromosome complex (red) was 
slowly moved to the end of the pipette and a suction force was made to take up a small amount 
of HVJ-E into the pipette. The recipient oocyte was immobilized so that the drilled hole of the 
zona was at 3 o’clock position. The red spindle-chromosome complex was gently released from 
the pipette and transferred into the enucleated recipient oocyte. After that, the reconstructed 
oocytes were briefly left in the manipulation drop to allow the fusion of the red 
spindle-chromosome complex and the recipient oocyte for 10-20 min. After fusion, the 
reconstructed oocytes were washed several times and placed in HTF medium for recovery and in 
vitro fertilization. See also Video S1. 
 
In Vitro Fertilization and culture after spindle transfer 
   Male mice (BDF1, 10–15 weeks) were sacrificed by cervical dislocation. After dissections, 
sperms were incubated for sperm capacitation in HTF medium at 37.5°C under 5% CO2, 5% O2, 
incubation for 1 h. Then 2 × 106 sperms/ml were added into the HTF drops containing the 
heteroplasmic oocytes after spindle transfer. The sperms and heteroplasmic oocytes were 
co-cultured at 37.5°C for at least 4~6 hrs. Then heteroplasmic oocytes were washed three times 
in G1 medium. Oocytes with two visible pronuclei (2PN) were considered fertilized and 
transferred into G1 medium (100 μl drop) and cultured up to 72 hours at 37.5 °C under 5% CO2, 
5% O2, and 90% N2 incubation. 
 
Living cell imaging of the whole embryos and its single blastomere developed from 
heteroplasmic oocytes 
   To visualize the distribution of foreign mitochondria upon division, embryos developed from 
heteroplasmy oocytes were transferred to a 35mm glass bottom dish for mitoTracker analysis 
(Leica Microsystems, Inc.). Fluorescent images were obtained at 5-μm Z-axis intervals under 
confocal microscope.  
   To quantify and explore the distribution of stained mitochondria in daughter blastomeres, 
blastomeres of the reconstructed embryos were disaggregated by brief exposure to 0.5% 
pronase and 0.05% trypsin-EDTA. Then all blastomeres of a whole embryo were transferred to a 
35mm glass bottom dish for analyzing distribution of stained mitochondria. Fluorescent images 
were obtained at 2-μm Z-axis intervals under confocal microscope. The relative fluorescent 
signals of blastomeres were determined using the Leica Application Suite-Advanced 
Fluorescence software. 
 
Statistical Analysis  
  Statistical analysis of mtDNA segregation was performed using GraphPad Prism 7. The 
normalised measure of heteroplasmy variance (V'(h)) was used to compare heteroplasmy 
variance among samples with different mean heteroplasmy, taking the form 
V(h) 	= V(h)E(h)	(1	 − 	E(h)) 
where V(h) is the variance of a set of samples and E(h) is its mean (Johnston et al., 2015, Johnston 
and Jones, 2016). To access donor mtDNA heteroplasmy in different tissues, Friedman test was 
used, where the significance was set at p < 0.05. For heteroplasmy level of three germ layers, 
Mann-Whitney test was performed, where the significance was set at p < 0.05. For correlation 
between heteroplasmy value and V'(h), Spearman correlation test was used, where the 
significance was set at p < 0.05. For spread range of heteroplasmy value, Mann-Whitney test was 
employed, where the significance was set at p < 0.05. To access V'(h) of different development 
stages, Mann-Whitney test was performed, where the significance was set at p < 0.05. For 
heteroplasmy level of different development stages, Mann-Whitney test was used, where the 
significance was set at p < 0.05. For heteroplasmy value distribution, Kolmogorov-Smirnov test 
was performed, where the significance was set at p < 0.05. To access variance of fluorescence 
intensity in blastomeres, Mann-Whitney test was employed, where the significance was set at p < 
0.05. Asterisks indicate statistical significance (∗ denotes a p value of < 0.05 and ∗∗ denotes a p 
value of < 0.01). 
 
